You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CARBINOXAMINE MALEATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for carbinoxamine maleate and what is the scope of patent protection?

Carbinoxamine maleate is the generic ingredient in three branded drugs marketed by Mcneil, Cypress Pharm, Endo Operations, Genus, Aytu, Invagen Pharms, Mikart, Mission Pharmacal, Strides Pharma, and Ortho Mcneil Pharm, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Carbinoxamine maleate has twenty-one patent family members in fourteen countries.

There are seven drug master file entries for carbinoxamine maleate. Eight suppliers are listed for this compound.

Drug Prices for CARBINOXAMINE MALEATE

See drug prices for CARBINOXAMINE MALEATE

Pharmacology for CARBINOXAMINE MALEATE
Anatomical Therapeutic Chemical (ATC) Classes for CARBINOXAMINE MALEATE

US Patents and Regulatory Information for CARBINOXAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharmacal CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090756-001 May 27, 2011 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Genus CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 040458-001 Apr 25, 2003 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ortho Mcneil Pharm CLISTIN carbinoxamine maleate TABLET;ORAL 008915-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CARBINOXAMINE MALEATE

Country Patent Number Title Estimated Expiration
China 102488652 Modified release formulations containing drug-ion exchange resin complexes ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2007109104 ⤷  Sign Up
Taiwan 200812649 Modified release formulations containing drug-ion exchange resin complexes ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.